Smoking Cessation, Provision of Prescription only Medication across Bradford District

The City of Bradford Metropolitan District Council is overseeing a procurement process for a smoking cessation scheme, titled "Smoking Cessation, Provision of Prescription only Medication across Bradford District." Classified under health services, the initiative is aimed at populations within the Bradford District, United Kingdom. The process is presently in the tender stage, with the tender period concluding on 7th November 2025.

Interested providers are required to submit tenders electronically and may raise enquiries until 27th October 2025. The contract, valued at up to £2,113,848 GBP, will commence on 18th December 2025 and could extend until 31st March 2029, contingent upon satisfactory performance and funding. This tender provides substantial opportunities for businesses specialising in health services, particularly those with expertise in prescribing medications like varenicline, cytisinicline (cytisine), or bupropion in clinical settings.

The scope for innovation and competitive differentiation is highlighted by a weighted award criterion focusing on quality, with emphasis on improving access and service sustainability. The open procedure fosters a competitive atmosphere, unlocking growth potential particularly for firms adept in addressing public health needs and enhancing community health services. Businesses with a strong track record in health interventions and a commitment to social value would be well-positioned to compete for this contract.